Investor Overview

Corporate Profile

Voyager Therapeutics is a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) technologies. Proprietary capsids born from the Company’s TRACER™ screening platform are powering a rich early-stage pipeline of new and second-generation programs and may elevate the field to overcome the limitations of conventional gene therapy vectors across neurologic disorders and other therapeutic areas. With a deep roster of experienced biopharmaceutical leaders and specialized expertise in gene therapy, the Voyager team is working relentlessly to develop new capsids that will enable safe and effective delivery of genetic payloads that could change the trajectory of disease and life as we know it for millions of people.

Our management team has deep expertise and a track record of building exceptional life science companies.

Upcoming Events

There are currently no upcoming events scheduled.